On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction ...

Bird & Bird wins in defending its clients in a major Supplementary Protection Certificate (SPC) case.

In 2017 the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).

The grant of a compulsory licence for the distribution of MSD’s HIV medicament “Isentress” (generic name raltegravir) by the German Federal Patent Court following the oral hearing on 30 and 31 August 2016 ...

Following an oral hearing held on 30 and 31 August 2016 the German Federal Patent Court (‘Bundespatentgericht’) has decided in preliminary injunction proceedings to grant Merck a compulsory licence for the ...

On 19 October 2016 the Court of Justice of the European Union handed down a judgment wherein it found that the current German fixed price regime for prescription drugs is in violation of the EU principle of free ...

Bird & Bird has been ranked in 15 jurisdictions in the newly-launched IAM Patent Litigation 1000: The World's Leading Patent Litigators (Europe & Asia).